Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors.
- DOI
- 10.1016/j.jtha.2026.05.028
- Published
- 2026-06-05
- Container
- J Thromb Haemost
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtha.2026.05.028,
title = {Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors.},
author = {Fusillo TF and Leader A and Mantha S and Ajufo H and Derkach A and Schoenfeld A and Singh R and Kaplinsky P and Zwicker JI.},
year = {2026},
journal = {J Thromb Haemost},
doi = {10.1016/j.jtha.2026.05.028},
url = {https://doi.org/10.1016/j.jtha.2026.05.028}
}RIS
TY - JOUR TI - Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors. AU - Fusillo TF AU - Leader A AU - Mantha S AU - Ajufo H AU - Derkach A AU - Schoenfeld A AU - Singh R AU - Kaplinsky P AU - Zwicker JI. PY - 2026 JO - J Thromb Haemost DO - 10.1016/j.jtha.2026.05.028 UR - https://doi.org/10.1016/j.jtha.2026.05.028 ER -
APA
TF, F., A, L., S, M., H, A., A, D., A, S., R, S., P, K., & JI., Z. (2026). Bleeding in patients with lung adenocarcinoma receiving concurrent administration of anticoagulation and vascular endothelial growth factor or epidermal growth factor receptor inhibitors.. J Thromb Haemost. https://doi.org/10.1016/j.jtha.2026.05.028
Source records
- europe-pmc · retrieved 2026-09-27T03:15:51.923Z